Neos Therapeutics, Inc
NEOS
NEOS was delisted on the 19th of March, 2021.
0 hedge funds and large institutions have $0 invested in Neos Therapeutics, Inc in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 36 closing their positions.
100% less funds holding
Funds holding: 37 → 0 (-37)
100% less capital invested
Capital invested by funds: $6.45M → $0 (-$6.45M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 36
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.06M |
| 3 |
Renaissance Technologies
New York
|
-$673K |
| 4 |
BlackRock
New York
|
-$251K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$212K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Bank of America
Charlotte,
North Carolina
| – | -$6K | -10,000 | Closed |
|
27
Cambridge Investment Research Advisors
Fairfield,
Iowa
| – | -$6K | -10,000 | Closed |
|
28
Group One Trading
Chicago,
Illinois
| – | -$5K | -8,605 | Closed |
|
29
Wells Fargo
San Francisco,
California
| – | -$2K | -2,924 | Closed |
|
30
Morgan Stanley
New York
| – | -$1K | -1,250 | Closed |
|
31
Citigroup
New York
| – | -$1K | -1,000 | Closed |
|
|
TFGT
32
TS Financial Group (TSFG)
Lake Forest,
Illinois
| – | -$1K | -200 | Closed |
|
33
BNP Paribas Financial Markets
Paris,
France
| – | -$6 | -10 | Closed |
|
NEOS Hedge Fund Activity: Q1 2021 in Review
0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q1 2021, worth a combined $0 — down 100% from $6.45M a quarter earlier.
Sellers outnumbered buyers: 36 funds closed out of NEOS and 0 opened new positions — a net loss of 36 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Stonepine Capital Management, exiting entirely with an estimated $3.1M sold.
- 0 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q1 2021, down from 37 in Q4 2020.
- Funds reported $0 of Neos Therapeutics, Inc stock for Q1 2021, down 100% quarter-over-quarter.
- 0 funds opened new Neos Therapeutics, Inc positions in Q1 2021 and 36 closed out, a net change of -36 holders.
- The largest Neos Therapeutics, Inc seller in Q1 2021 was Stonepine Capital Management, an estimated $3.1M sold.
Based on aggregated 13F filings for Q1 2021.